Indeed, TNFB is found to be elevated in the CSF of individuals with relapsing MS exhibiting a high number of cortical lesions and in people with progressive MS with high burden of gray matter demyelination in post-mortem brains, also suggesting the prognostic significance of this protein [58]. This evidence concerns the gene LTA and myeloid sarcoma.